Foghorn Therapeutics Inc. (FHTX) Reports In-Line Q1 EPS

Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.73), in-line with the analyst estimate of ($0.73). Revenue for the quarter came in at $5.31 million versus the consensus estimate of $4.22 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.

You May Also Be Interested In

• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Scout24 (G24:GR) (SCOTF) PT Raised to EUR140 at Berenberg
• Grafton Group PLC (GFTU:LN) PT Raised to GBP11.50 at Berenberg